TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 12 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $57,000 | 0.0% | 58,000 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $57,000 | 0.0% | 58,000 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $57,000 | +5.6% | 58,000 | 0.0% | 0.01% | -11.1% |
| Q1 2020 | $54,000 | -1.8% | 58,000 | 0.0% | 0.01% | +50.0% |
| Q4 2019 | $55,000 | +3.8% | 58,000 | 0.0% | 0.01% | -14.3% |
| Q3 2019 | $53,000 | 0.0% | 58,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $53,000 | -1.9% | 58,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $54,000 | +3.8% | 58,000 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $52,000 | -5.5% | 58,000 | 0.0% | 0.01% | +14.3% |
| Q3 2018 | $55,000 | +1.9% | 58,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $54,000 | +5.9% | 58,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $51,000 | -3.8% | 58,000 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $53,000 | – | 58,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Asset Management Company, LLC | 31,076,000 | $29,006,000 | 23.36% |
| INCOME RESEARCH & MANAGEMENT | 15,589,000 | $14,254,000 | 7.13% |
| SYMPHONY ASSET MANAGEMENT LLC | 17,600,000 | $16,378,000 | 5.14% |
| PenderFund Capital Management Ltd. | 8,470,000 | $11,097,000 | 3.46% |
| Radcliffe Capital Management, L.P. | 15,823,000 | $14,645,000 | 2.75% |
| LMR Partners LLP | 34,735,000 | $32,172,000 | 1.50% |
| Bracebridge Capital, LLC | 5,500,000 | $5,000,000 | 0.91% |
| Penn Capital Management Company, LLC | 5,079,000 | $4,701,000 | 0.78% |
| ONTARIO TEACHERS PENSION PLAN BOARD | 17,400,000 | $16,191,000 | 0.44% |
| WESTWOOD HOLDINGS GROUP INC | 29,605,000 | $27,715,000 | 0.42% |